Testing for Recureent Miscarriages
Question:
Testing For Recurrent Miscarriages One in 300 pregnancies is due to recurrent pregnancy loss. More than half of all these cases undiagnosed recurrent pregnancy losses are evaluated and tested for both Genetic and Immunological (autoimmune) problems. The most common tests are Phospholipid, Cardiolipin and ANA antibodies along with Embryo Toxic Factor and Natural Killer cells. Other tests included Leucocyte Antibody Detection. Properly selected test panels will assist your Physician in determining the autoimmune or Genetic cause of this persistent condition. Various therapies are available based upon the results of the evaluation performed. These include IVIG, Immunosuppressive, Steriods, baby aspirin, and heparin and white blood cell Immunolotherapy. This highly complex specialized testing is only offered by a few reproductive labs in the world. also visit our website at www.repromedix.cim
Response:
As a moderator of the newsgroup soc.support.pregnancy.loss which actually deals with miscarriage and of course recurrent miscarriage, and as a support contact for a voluntary organisation called The Miscarriage Association in the United Kingdom, I am very interested in finding out where your quoted statistic of "one in 300 pregnancies is due to recurrent pregnancy loss". Where does this figure come from? Is that based on a study, in which case, which study is it? What does this figure actually mean? How can a pregnancy be due to loss? Or are you saying that one in 300 pregnancies are a result of a treated cause of recurrent miscarriage? I am very interested to hear further details from you. Janet Sackman
Response:
Maybe it’s a typo and it’s supposed to read "one in 300 pregnancies *lost* is due to recurrent pregnancy loss"?! Just a thought… – Leigh 7 unsuccessful cycles of Clomid still waiting for initial appointment with RE low sperm count and poor motility for DH … possible PCOS for me
Response:
Filed under: PCOS
Leave a Comment
XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>
TrackBack URL | RSS feed for comments on this post.